# EMED (Electromedical Technologies, Inc.) - SEC EDGAR Financial Statements

> Electromedical Technologies, Inc. reported $922K in revenue and a net loss of $1.68M for the trailing twelve months ended September 30, 2024 (down 86.9% year over year), with a 75.1% gross margin and a -109.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/EMED
- Markdown: https://convexityos.com/fundamentals/EMED.md
- SEC CIK: 0001715819
- Reporting currency: USD
- Latest filing period: September 30, 2024
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001715819&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $922K | -86.9% YoY |
| Operating Income | TTM | -$1.01M | -109.6% margin |
| Net Income | TTM | -$1.68M | -182.0% net margin |
| Diluted EPS | TTM | $0.00 | Split-adjusted |
| Free Cash Flow | TTM | -$1.57M | -170.0% FCF margin |
| Cash & ST Investments | Sep 30, 2024 | $35K | Total debt: $132K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.35M | $1.15M | $907K | $738K | $830K |
| Cost of Revenue | $303K | $261K | $199K | $194K | $239K |
| **Gross Profit** | $1.05M | $889K | $708K | $544K | $591K |
| Research & Development | $231K | $92K | $215K | $32K | $83K |
| Selling, General & Admin | $3.11M | $2.49M | $4.51M | $3.71M | $2.26M |
| **Operating Income** | -$2.06M | -$1.60M | -$3.80M | -$3.17M | -$1.67M |
| **EBITDA** | -$2.06M | -$1.58M | -$3.78M | -$3.14M | -$1.64M |
| Interest Expense | $893K | $791K | $3.31M | $770K | $55K |
| **Net Income** | -$2.64M | -$3.47M | -$8.48M | -$3.87M | -$1.74M |
| Basic EPS | $0.00 | -$0.03 | -$0.24 | -$0.20 | -$0.10 |
| **Diluted EPS** | $0.00 | -$0.03 | -$0.24 | -$0.20 | -$0.10 |
| Basic Shares Outstanding | 377.2M | 133.6M | 51.0M | 22.3M | 16.8M |
| Diluted Shares Outstanding | 377.2M | 133.6M | 51.0M | 22.3M | 16.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $43K | $238K | $290K | $352K | $324K | $295K | $379K | $423K |
| Cost of Revenue | $12K | $64K | $73K | $81K | $72K | $63K | $88K | $90K |
| **Gross Profit** | $31K | $173K | $217K | $271K | $251K | $232K | $291K | $333K |
| Selling, General & Admin | $412K | $425K | $372K | $494K | $490K | $574K | $1.55M | $590K |
| **Operating Income** | -$381K | -$252K | -$155K | -$223K | -$239K | -$341K | -$1.26M | -$257K |
| **EBITDA** | -$381K | -$252K | -$155K | -$223K | -$239K | -$341K | -$1.26M | -$252K |
| Interest Expense | $55K | $58K | $59K | $58K | $162K | $284K | $388K | $281K |
| **Net Income** | -$725K | $231K | -$836K | -$349K | -$377K | -$1.46M | -$456K | -$830K |
| Basic EPS | $0.00 | $0.00 | -$0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| **Diluted EPS** | -- | $0.00 | -$0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| Basic Shares Outstanding | 681.0M | 566.7M | 464.8M | -- | 466.2M | 335.0M | 240.6M | -- |
| Diluted Shares Outstanding | -- | 1.94B | 464.8M | -- | 466.2M | 335.5M | 240.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $88K | $368K | $383K | $265K | $0 |
| **Cash & Short-Term Investments** | $88K | $368K | $383K | $265K | $0 |
| Accounts Receivable, Net | $4.4K | $9.4K | $35K | $18K | $16K |
| Inventory | $69K | $62K | $219K | $79K | $25K |
| **Total Current Assets** | $449K | $648K | $675K | $647K | $106K |
| Property, Plant & Equipment, Net | $150K | $705K | $727K | $749K | $771K |
| Other Non-Current Assets | -- | -- | -- | $21K | $26K |
| **Total Non-Current Assets** | $299K | $705K | $727K | $770K | $797K |
| **Total Assets** | $748K | $1.35M | $1.40M | $1.42M | $903K |
| Accounts Payable | $239K | $267K | $215K | $263K | $251K |
| Deferred Revenue (Current) | $197K | $218K | $0 | $29K | $40K |
| **Total Current Liabilities** | $3.36M | $2.92M | $1.44M | $2.02M | $2.30M |
| Long-Term Debt | $150K | $672K | $703K | $732K | -- |
| Other Non-Current Liabilities | $8.4K | $10K | $9.2K | $16K | $11K |
| **Total Non-Current Liabilities** | $265K | $650K | $682K | $716K | $791K |
| **Total Liabilities** | $3.62M | $3.57M | $2.12M | $2.74M | $3.09M |
| **Total Debt (incl. Leases)** | $460K | $672K | $703K | $732K | -- |
| Common Stock | $4.6K | $1.9K | $876 | $269 | $177 |
| Retained Earnings | -$27.47M | -$24.83M | -$21.88M | -$9.63M | -$5.25M |
| **Total Stockholders' Equity** | -$2.87M | -$2.22M | -$723K | -$1.32M | -$2.18M |
| Total Equity | -$2.87M | -$2.22M | -$723K | -$1.32M | -$2.18M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35K | $117K | $79K | $88K | $138K | $416K | $1.24M | $368K |
| **Cash & Short-Term Investments** | $35K | $117K | $79K | $88K | $138K | $416K | $1.24M | $368K |
| Accounts Receivable, Net | $7.3K | $4.3K | $3.5K | $4.4K | $9.2K | $26K | $5.8K | $9.4K |
| Inventory | $24K | $32K | $47K | $69K | $131K | $113K | $160K | $62K |
| **Total Current Assets** | $305K | $389K | $419K | $449K | $543K | $882K | $1.57M | $648K |
| Property, Plant & Equipment, Net | $150K | $150K | $150K | $150K | $150K | $150K | -- | $705K |
| **Total Non-Current Assets** | $263K | $276K | $288K | $299K | $310K | $150K | $0 | $705K |
| **Total Assets** | $569K | $665K | $707K | $748K | $853K | $1.03M | $1.57M | $1.35M |
| Accounts Payable | $226K | $240K | $242K | $239K | $278K | $269K | $544K | $267K |
| Deferred Revenue (Current) | $764K | $438K | $185K | $197K | $130K | $238K | $134K | $218K |
| **Total Current Liabilities** | $4.36M | $3.83M | $4.15M | $3.36M | $3.09M | $3.15M | $2.44M | $2.92M |
| Long-Term Debt | -- | -- | -- | $150K | -- | -- | -- | $672K |
| Other Non-Current Liabilities | $3.4K | $5.0K | $6.3K | $8.4K | $9.2K | $10.0K | $11K | $10K |
| **Total Non-Current Liabilities** | $218K | $234K | $249K | $265K | $278K | $160K | $161K | $650K |
| **Total Liabilities** | $4.57M | $4.06M | $4.40M | $3.62M | $3.37M | $3.31M | $2.60M | $3.57M |
| **Total Debt (incl. Leases)** | $132K | $263K | $287K | $460K | $166K | -- | -- | $672K |
| Common Stock | $7.3K | $5.7K | $4.9K | $4.6K | $4.7K | $4.3K | $3.0K | $1.9K |
| Retained Earnings | -$28.80M | -$28.07M | -$28.31M | -$27.47M | -$27.12M | -$26.74M | -$25.28M | -$24.83M |
| **Total Stockholders' Equity** | -$4.00M | -$3.40M | -$3.69M | -$2.87M | -$2.52M | -$2.28M | -$1.03M | -$2.22M |
| Total Equity | -$4.00M | -$3.40M | -$3.69M | -$2.87M | -$2.52M | -$2.28M | -$1.03M | -$2.22M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$2.64M | -$3.47M | -$8.48M | -$3.87M | -$1.74M |
| Depreciation & Amortization | $4.6K | $22K | $22K | $22K | $24K |
| Stock-Based Compensation | $715K | $510K | $2.63M | $2.22M | $801K |
| Change in Receivables | $3.2K | $26K | -$17K | -$5.8K | -$1.9K |
| Change in Inventory | -$6.5K | $156K | -$140K | -$54K | -- |
| Change in Payables | -$27K | $52K | -$41K | $11K | $84K |
| **Operating Cash Flow** | -$1.42M | -$773K | -$1.19M | -$1.34M | -$281K |
| Capital Expenditure | -$150K | -- | -- | -- | -- |
| **Free Cash Flow** | -$1.57M | -- | -- | -- | -- |
| **Investing Cash Flow** | $1.74M | -- | -- | -- | -- |
| Common Stock Issued | -- | $43K | -- | $14K | $110K |
| **Financing Cash Flow** | -$608K | $759K | $1.31M | $1.60M | $281K |
| **Net Change in Cash** | -$281K | -$15K | $118K | $265K | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$725K | $231K | -$836K | -$349K | -$377K | -$1.46M | -$456K | -$830K |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $0 | $4.6K | $5.5K |
| Stock-Based Compensation | -- | -- | -- | $0 | $0 | $0 | $715K | $25K |
| Change in Receivables | -$2.9K | -$837 | $898 | $3.0K | $17K | -$20K | $3.6K | $7.2K |
| Change in Inventory | $7.4K | $15K | $22K | $63K | -$18K | $47K | -$98K | $55K |
| Change in Payables | -$15K | -$1.6K | $2.5K | -$38K | $8.2K | -$274K | $277K | -$10K |
| **Operating Cash Flow** | -$31K | $109K | -$158K | -$51K | -$278K | -$636K | -$453K | -$33K |
| **Investing Cash Flow** | -- | -- | -- | $0 | $0 | -$150K | $1.89M | -- |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -$51K | -$71K | $150K | $175 | $0 | -$33K | -$575K | -$57K |
| **Net Change in Cash** | -$82K | $38K | -$8.9K | -$51K | -$278K | -$819K | $867K | -$90K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 77.5% | 77.3% | 78.0% | 73.7% | 71.3% |
| **Operating Margin** | -153.1% | -139.5% | -418.8% | -429.1% | -201.1% |
| **Net Profit Margin** | -195.8% | -301.6% | -934.6% | -524.7% | -210.2% |
| Return on Assets (ROA) | -352.9% | -256.3% | -604.8% | -273.2% | -193.2% |
| Current Ratio | 0.13x | 0.22x | 0.47x | 0.32x | 0.05x |
| Quick Ratio | 0.11x | 0.20x | 0.32x | 0.28x | 0.04x |
| **Revenue Growth (YoY)** | +17.3% | +26.7% | +23.0% | -11.1% | -- |
| Gross Profit Growth (YoY) | +17.7% | +25.5% | +30.3% | -8.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 75.1% | 75.9% | 77.1% | 77.5% | 78.0% | 78.3% | 78.5% | 77.3% |
| **Operating Margin** | -109.6% | -72.2% | -76.0% | -153.1% | -147.8% | -159.7% | -163.7% | -139.5% |
| **Net Profit Margin** | -182.0% | -110.6% | -239.7% | -195.8% | -219.9% | -269.1% | -212.8% | -301.6% |
| Return on Assets (ROA) | -295.1% | -200.1% | -427.3% | -352.9% | -365.9% | -359.0% | -177.0% | -256.3% |
| Current Ratio | 0.07x | 0.10x | 0.10x | 0.13x | 0.18x | 0.28x | 0.64x | 0.22x |
| Quick Ratio | 0.06x | 0.09x | 0.09x | 0.11x | 0.13x | 0.24x | 0.58x | 0.20x |
| **Revenue Growth (YoY)** | -86.9% | -19.4% | -23.3% | -16.9% | +15.8% | +30.9% | +70.6% | +78.7% |
| Gross Profit Growth (YoY) | -87.8% | -25.5% | -25.3% | -18.6% | +13.4% | +29.2% | +88.6% | +70.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
